Patent assignee · US · COMPANY

EPICENTRX, INC.

30Patents
30Active
30Granted
55Portfolio score

Filing activity: Sep 6, 2007 → Apr 29, 2024 · 1 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US9139519B2 Organonitro thioether compounds and medical uses thereof Chemistry; Metallurgy 16 Active
US8927527B2 Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof Chemistry; Metallurgy 16 Active
US9468625B2 Organonitro thioether compounds and medical uses thereof Chemistry; Metallurgy 14 Active
US9226915B2 Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof Chemistry; Metallurgy 14 Active
US9987270B1 Treatment of gliomas using organonitro compound combination therapy Human Necessities 13 Active
US10342778B1 Treatment of brain metastases using organonitro compound combination therapy Human Necessities 12 Active
US10543208B2 Treatment of gliomas using organonitro compound combination therapy Human Necessities 11 Active
US10149832B2 Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof Chemistry; Metallurgy 11 Active
US11008287B2 Sulfoxyalkyl organonitro and related compounds and pharmaceutical compounds for use in medicine Emerging Cross-Sectional Technologies 9 Active
US11160784B1 Treatment of brain metastases using organonitro compound combination therapy Human Necessities 8 Active
US11510901B2 Methods and compositions utilizing RRx-001 combination therapy for radioprotection Human Necessities 6 Active
US11576895B2 Compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone Human Necessities 4 Active
US9511016B2 Topical composition for treating pain Human Necessities 4 Active
US11744859B2 Compositions and methods for parenteral administration of therapeutic agents Emerging Cross-Sectional Technologies 2 Active
US10906957B2 Immunomodulatory fusion proteins Chemistry; Metallurgy 2 Active
US11701351B2 Treatment of gliomas using organonitro compound combination therapy Human Necessities 2 Active
US11925617B2 Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof Chemistry; Metallurgy 2 Active
US11660286B2 Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood products Emerging Cross-Sectional Technologies 2 Active
US12109348B2 Medication infusion devices, systems, and methods Human Necessities 2 Active
US12048793B2 Medication infusion devices, systems, and methods Human Necessities 2 Active
US11834492B2 Human IL-10 receptor alpha fusion proteins Chemistry; Metallurgy 1 Active
US11253608B2 Recombinant adenoviruses carrying transgenes Chemistry; Metallurgy 1 Active
US12291726B2 A549 host cells comprising a recombinant oncolytic adenovirus with modified E1A cancer-specific promoter Chemistry; Metallurgy 0 Active
US11999973B2 Method for producing recombinant oncolytic adenovirus with modified E1a cancer-specific promoter Chemistry; Metallurgy 0 Active
US12054530B2 Immunomodulatory fusion proteins Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.